Characterization of a Cr51-labeled endotoxin and its identification in plasma and urine after parenteral administration.
about
Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes.Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats.Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected miceMitogenic activity of staphylococcal peptidoglycanStudies with radioactive endotoxin. I. Clearance of 51Cr-labelled endotoxin from the blood of calves.Studies with radioactive endotoxin. II. Clearance of 3H-labelled endotoxin from the blood of calves.Fate of 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice.Inheritance of lipopolysaccharide-enhanced nonspecific resistance to infection and of susceptibility to endotoxic shock in lipopolysaccharide low-responder miceTime course of cellular distribution of endotoxin in liver, lungs and kidneys of rats.Host defense against bacterial endotoxemia: mechanism in normal animalsIdentification of the toxic component of Brucella abortus endotoxin and its labeling with radioactive chromateImmunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.Blastic transformtion of mouse spleen lymphocytes by a water-soluble mitogen extracted from Nocardia.In vivo interaction of endotoxin with a plasma lipoprotein having esterase activity.Hybridization by deoxycholate treatment or by biological degradation of bacterial endotoxins extracted from smooth and rough strains.A study of particle sizes, shapes and toxicities present in a boivin-type endotoxic preparation.
P2860
Q33410141-F0AFF538-81A6-40C0-A169-AD45AF5CA81DQ33902503-57645478-D0FF-4D11-BC57-D7C59E729954Q33903620-CA44BC57-671F-4179-8968-4789A72A6D34Q34080047-B7DDAB81-94B9-402A-B4C5-8E96582EDF18Q34238352-38CE0E5D-C1CC-4E4D-ABD2-78A99ABAECD9Q34238358-92FCE789-EF50-45C7-99AC-03CAF4D075EEQ34399435-F7DD3646-4A86-4AAF-A485-0872C2A318D0Q34405903-482C417E-8E3A-497A-ABFC-7D54806D94AAQ36089838-9D291FD9-F345-4A64-AC74-6050B8A6C107Q36270002-E7C46000-28D7-4BEA-A2C2-6615AFB07C94Q36847334-7482F80C-6536-4235-A2C6-291B2CD546D0Q37195451-ACA8F8C6-71F8-41D6-8CFA-885A9B9AA359Q37441558-D3D7F720-3D04-4B23-A5B4-B14D41A18339Q40435897-13FF847C-8BF2-43B2-AD2F-AA7090ACBEB1Q40883842-3C3B4AFA-F330-4C02-99C4-DCC618097845Q53918048-AE929202-46F4-4ECD-9FDC-4BF0F8299D35
P2860
Characterization of a Cr51-labeled endotoxin and its identification in plasma and urine after parenteral administration.
description
1963 nî lūn-bûn
@nan
1963年の論文
@ja
1963年学术文章
@wuu
1963年学术文章
@zh-cn
1963年学术文章
@zh-hans
1963年学术文章
@zh-my
1963年学术文章
@zh-sg
1963年學術文章
@yue
1963年學術文章
@zh
1963年學術文章
@zh-hant
name
Characterization of a Cr51-lab ...... ter parenteral administration.
@ast
Characterization of a Cr51-lab ...... ter parenteral administration.
@en
type
label
Characterization of a Cr51-lab ...... ter parenteral administration.
@ast
Characterization of a Cr51-lab ...... ter parenteral administration.
@en
prefLabel
Characterization of a Cr51-lab ...... ter parenteral administration.
@ast
Characterization of a Cr51-lab ...... ter parenteral administration.
@en
P2093
P2860
P356
P1476
Characterization of a Cr51-lab ...... ter parenteral administration.
@en
P2093
P2860
P304
P356
10.1084/JEM.117.4.561
P407
P577
1963-04-01T00:00:00Z